08.09.2009
Rob Koremans appointed Senior Vice President, Generics Europe and President of Zentiva
September 2, 2009 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) is pleased to announce today that Rob Koremans ...
|
28.04.2009
Delisting of Zentiva’s shares from the Prague Stock Exchange
Prague, April 28, 2009 – Zentiva N.V. (the “Company” or “Zentiva”) hereby announces that the termination of the listing of its ordinary ...
|
24.04.2009
Zentiva N.V. – Cancellation of the Listing of Global Depositary Shares Becomes Effective
Prague, London, April 24, 2009 – Zentiva N.V. (the “Company” or “Zentiva”) hereby announces that the termination of the listing of its outstanding global ...
|
02.04.2009
Zentiva N.V. - Results of Extraordinary General Meeting held on April 2, 2009
Prague, London, April 2, 2009 - Zentiva N.V. (“Zentiva” or the “Company”) is pleased to announce that it held its Extraordinary ...
|
24.03.2009
Zentiva to apply for termination of its listing on the Prague Stock Exchange
Prague, London, March 24, 2009 – Today, Zentiva N.V. (the “Company” or “Zentiva”) applied to the Prague Stock Exchange for termination ...
|
24.03.2009
Zentiva N.V. – Notice of Intention to Cancel the Listing of Global Depositary Shares
Prague, London, March 24, 2009 – Zentiva N.V. (the “Company” or “Zentiva”) hereby announces, in accordance with the requirement ...
|
23.03.2009
Zentiva produces strong 2008 operating results
Larger, better balanced business delivers expected sales
and efficiency benefits
EBIT increased ...
|
12.03.2009
Sanofi-Aventis becomes majority shareholder of Zentiva
Prague, London, March 12, 2009 – Today, Sanofi-Aventis Europe announced that it has became an approximately 96.8% shareholder of Zentiva ...
|
11.03.2009
Zentiva issues new shares
Zentiva Board decides to initiate delisting from the Prague Stock Exchange
Prague, London, March 11, 2009 – Today, ...
|
25.02.2009
Sanofi-Aventis announces successful takeover of Zentiva
Prague, London, February 25, 2009 – Sanofi-Aventis announced today that all of the conditions to its recommended voluntary CZK ...
|
13.02.2009
Zentiva to issue new shares to cover exercised employee stock options
Prague, London, February 13, 2009 – Zentiva N.V. ("Zentiva" or the “Company") announces that its Board has decided on the conditional ...
|
10.02.2009
PPF withdraws its court action against Zentiva
Prague, London, February 10, 2009 – Zentiva N.V. ("Zentiva" or the “Company") notes the announcement by Anthiarose Limited, a wholly ...
|
09.02.2009
Zentiva N.V. - Results of Extraordinary General Meeting held on February 9, 2009
Prague, London, February 9, 2009– Zentiva N.V. (“Zentiva” or the “Company”) is pleased to announce that it held its Extraordinary ...
|
04.02.2009
The European Commission clears acquisition of Zentiva by Sanofi-Aventis
The Board of Directors of Zentiva continues to recommend the improved Sanofi-Aventis takeover offer of CZK 1,150 in cash per share
Zentiva ...
|
04.02.2009
PPF notifies Zentiva of court action to attempt to call EGM to replace Zentiva's Board
ZENTIVA BELIEVES PPF’S SUIT IS WITHOUT MERIT
Prague, London, February 4, 2009 – Zentiva N.V. ("Zentiva" or ...
|
10.11.2008
Zentiva produces strong first nine month results
Successful Integration of the Turkish Business and Focus on Efficiency Lead to 61.7% increase in EBIT to CZK 2,361.2 million
1
Prague, ...
|
22.10.2008
Zentiva’s Expects to Report a 18% Increase in Nine Month 2008 Sales
Zentiva’s Expects to Report a 18% Increase ...
|
22.09.2008
The Board of Directors of Zentiva recommends the intended improved offer for Zentiva by Sanofi-Aventis for CZK 1,150 in Cash per Share
This announcement does not constitute a public offer for ordinary shares and/or global depository shares in the capital ...
|
03.09.2008
Zentiva N.V. – Sanofi Offer Update
Board Continues To Advise Shareholders To Reject The Sanofi Offer As It Fails To Reflect Zentiva’s Fundamental Value
Prague, ...
|
03.09.2008
Zentiva N.V. - Results of Extraordinary General Meeting held on September 3, 2008
Prague, London, September 3, 2008 - Zentiva N.V. (“Zentiva” or the “Company”) is pleased to announce that it held its Extraordinary ...
|
|
1
2
3
4
|
| |